Jian Zhou, Huichuan Sun, Zheng-Lin Wang, W. Cong, Jian-hua Wang, M. Zeng, Weiping Zhou, P. Bie, Lian-Xin Liu, T. Wen, G. Han, Maoqiang Wang, Ruibao Liu, Ligong Lu, Zheng-Gang Ren, Minshan Chen, Z. Zeng, P. Liang, C. Liang, Min Chen, Fuhua Yan, Wenping Wang, Yuan Ji, J. Yun, Dingfang Cai, Yongjun Chen, W. Cheng, Shuqun Cheng, C. Dai, Wenzhi Guo, B. Hua, Xiaowu Huang, W. Jia, Yaming Li, Yexiong Li, Jun Liang, Tianshu Liu, Guoyue Lv, Y. Mao, T. Peng, W. Ren, Hongcheng Shi, G. Shi, K. Tao, Wentao Wang, Xiaoying Wang, Zhiming Wang, Bangde Xiang, B. Xing, Jianming Xu, Jiamei Yang, Jian-yong Yang, Yefa Yang, Yunke Yang, S. Ye, Zhengyu Yin, Bixiang Zhang, Boheng Zhang, Leida Zhang, Shuijun Zhang, Ti Zhang, Yong-fu Zhao, Honggang Zheng, Jiye Zhu, K. Zhu, Rong Liu, Yinghong Shi, Yong-Sheng Xiao, Z. Dai, G. Teng, J. Cai, Weilin Wang, Xiujun Cai, Qiang Li, F. Shen, S. Qin, Jiahong Dong, Jia Fan
2020.11.11Liver Cancer
tlooto Summary
The new guidelines were endorsed and promulgated by the Bureau of Medical Administration of the National Health Commission of the People’s Republic of China in December 2019 and reflect the real-world situation in China regarding diagnosing and treating liver cancer in recent years.
Abstract
Background: Primary liver cancer, around 90% are hepatocellular carcinoma in China, is the fourth most common malignancy and the second leading cause of tumor-related death, thereby posing a significant threat to the life and health of the Chinese people. Summary: Since the publication of Guidelines for Diagnosis and Treatment of Primary Liver Cancer (2017 Edition) in 2018, additional high-quality evidence has emerged with relevance to the diagnosis, staging, and treatment of liver cancer in and outside China that requires the guidelines to be updated. The new edition (2019 Edition) was written by more than 70 experts in the field of liver cancer in China. They reflect the real-world situation in China regarding diagnosing and treating liver cancer in recent years. Key Messages: Most importantly, the new guidelines were endorsed and promulgated by the Bureau of Medical Administration of the National Health Commission of the People’s Republic of China in December 2019.
Citation format
ZHOU, Jian, et al. Guidelines for the diagnosis and treatment of hepatocellular carcinoma (2019 edition). Liver Cancer, 2020, 9: 682–720.